PL1785137T3 - Środek do leczenia hiperlipemii - Google Patents

Środek do leczenia hiperlipemii

Info

Publication number: PL1785137T3
Authority: PL; Poland
Prior art keywords: hyperlipemia; remedy; pitavastatin; ezetimibe; hypercholesterolemia
Prior art date: 2004-08-31

Application number

PL05777087T

Other languages

English (en)

Inventor

Taro Aoki

Hiroyuki Yamazaki

Takashi Maejima

Original Assignee

Kowa Co

Nissan Chemical Ind Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-31

Filing date

2005-08-30

Publication date

2011-04-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35944235&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1785137(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-08-30 Application filed by Kowa Co, Nissan Chemical Ind Ltd filed Critical Kowa Co

2011-04-29 Publication of PL1785137T3 publication Critical patent/PL1785137T3/pl

Links

201000005577 familial hyperlipidemia Diseases 0.000 title abstract 2
208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
OLNTVTPDXPETLC-XPWALMASSA-N ezetimibe Chemical class N1([C@@H]([C@H](C1=O)CC[C@H](O)C=1C=CC(F)=CC=1)C=1C=CC(O)=CC=1)C1=CC=C(F)C=C1 OLNTVTPDXPETLC-XPWALMASSA-N 0.000 abstract 1
229960000815 ezetimibe Drugs 0.000 abstract 1
150000002596 lactones Chemical class 0.000 abstract 1
VGYFMXBACGZSIL-MCBHFWOFSA-N pitavastatin Chemical class OC(=O)C[C@H](O)C[C@H](O)\C=C\C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1 VGYFMXBACGZSIL-MCBHFWOFSA-N 0.000 abstract 1
229960002797 pitavastatin Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Obesity (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Quinoline Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)
Saccharide Compounds (AREA)

PL05777087T 2004-08-31 2005-08-30 Środek do leczenia hiperlipemii PL1785137T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US60552504P	2004-08-31	2004-08-31
US10/997,878 US20060046996A1 (en)	2004-08-31	2004-11-29	Method for treating hyperlipidemia
EP05777087A EP1785137B1 (en)	2004-08-31	2005-08-30	Remedy for hyperlipemia
PCT/JP2005/015756 WO2006025378A1 (ja)	2004-08-31	2005-08-30	高脂血症治療剤

Publications (1)

Publication Number	Publication Date
PL1785137T3 true PL1785137T3 (pl)	2011-04-29

Family

ID=35944235

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05777087T PL1785137T3 (pl)	2004-08-31	2005-08-30	Środek do leczenia hiperlipemii

Country Status (12)

Country	Link
US (2)	US20060046996A1 (pl)
EP (1)	EP1785137B1 (pl)
JP (1)	JP4886516B2 (pl)
KR (1)	KR101244508B1 (pl)
CN (1)	CN101010080B (pl)
AT (1)	ATE489093T1 (pl)
CY (1)	CY1111150T1 (pl)
DE (1)	DE602005024981D1 (pl)
ES (1)	ES2354366T3 (pl)
PL (1)	PL1785137T3 (pl)
PT (1)	PT1785137E (pl)
WO (1)	WO2006025378A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0215579D0 (en) *	2002-07-05	2002-08-14	Astrazeneca Ab	Chemical compounds
WO2004091660A1 (ja) *	2003-04-17	2004-10-28	Kowa Co., Ltd.	Lklf/klf2遺伝子発現促進剤
ATE485267T1 (de) *	2003-12-23	2010-11-15	Astrazeneca Ab	Diphenylazetidinonderivate mit die cholesterinabsorption hemmender wirkung
GB0329778D0 (en) *	2003-12-23	2004-01-28	Astrazeneca Ab	Chemical compounds
TW200619204A (en) *	2004-12-10	2006-06-16	Kowa Co	Method for reduction, stabilization and prevention of rupture of lipid rich plaque
UY29607A1 (es) *	2005-06-20	2007-01-31	Astrazeneca Ab	Compuestos quimicos
SA06270191B1 (ar) *	2005-06-22	2010-03-29	استرازينيكا ايه بي	مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
AR054482A1 (es) *	2005-06-22	2007-06-27	Astrazeneca Ab	Derivados de azetidinona para el tratamiento de hiperlipidemias
AR057072A1 (es) *	2005-06-22	2007-11-14	Astrazeneca Ab	Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
AR057380A1 (es) *	2005-06-22	2007-11-28	Astrazeneca Ab	Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
AR057383A1 (es) *	2005-06-22	2007-12-05	Astrazeneca Ab	Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
TW200811098A (en) *	2006-04-27	2008-03-01	Astrazeneca Ab	Chemical compounds
UA108742C2 (uk)	2009-09-23	2015-06-10		Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
US20130023513A1 (en) *	2010-01-12	2013-01-24	Hughes Thomas E	Methods and Compositions for Treating Cardiovascular Disorders
TWI586380B (zh) *	2013-12-18	2017-06-11	夢製藥公司	包含ＨＭＧ－ＣｏＡ還原酶抑制劑及膽固醇吸收抑制劑之醫藥組合製劑
US10413543B2 (en) *	2015-09-01	2019-09-17	Sun Pharma Advanced Research Company Ltd.	Stable multiparticulate pharmaceutical composition of rosuvastatin
JP6937195B2 (ja) *	2017-09-01	2021-09-22	興和株式会社	医薬組成物
JPWO2020178878A1 (pl) *	2019-03-01	2020-09-10
US11833133B2 (en) *	2020-08-13	2023-12-05	Orient Pharma Co., Ltd.	Solid oral pharmaceutical composition
PT4566591T (pt)	2023-12-07	2026-03-20	Krka D D Novo Mesto	Forma de dosagem farmacêutica sólida compreendendo ezetimiba e pitavastatina

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5854259A (en) *	1987-08-20	1998-12-29	Nissan Chemical Industries Ltd.	Quinoline type mevalonolactones
US5185328A (en) *	1987-08-20	1993-02-09	Nissan Chemical Industries Ltd.	Quinoline type mevalonolactones useful for treating hyperlipidemia, hyperlipoproteinemia or atherosclerosis
JP2569746B2 (ja) *	1987-08-20	1997-01-08	日産化学工業株式会社	キノリン系メバロノラクトン類
LT3300B (en) *	1992-12-23	1995-06-26	Schering Corp	Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor
US5631365A (en)	1993-09-21	1997-05-20	Schering Corporation	Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US6465477B1 (en) *	1997-08-18	2002-10-15	Kowa Company, Ltd.	Stable pharmaceutical composition
US7148197B2 (en) *	2000-08-24	2006-12-12	The Regents Of The University Of California	Orally administered small peptides synergize statin activity
KR20040026705A (ko) *	2001-08-16	2004-03-31	테바 파마슈티컬 인더스트리즈 리미티드	스타틴의 칼슘 염 형태의 제조 방법
AR040588A1 (es) *	2002-07-26	2005-04-13	Schering Corp	Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
AU2006204334B2 (en) *	2005-01-10	2012-02-23	Cortendo Ab (Publ)	Methods and compositions for treating diabetes, metabolic syndrome and other conditions

2004
- 2004-11-29 US US10/997,878 patent/US20060046996A1/en not_active Abandoned
2005
- 2005-08-30 EP EP05777087A patent/EP1785137B1/en not_active Revoked
- 2005-08-30 JP JP2006532716A patent/JP4886516B2/ja not_active Expired - Lifetime
- 2005-08-30 WO PCT/JP2005/015756 patent/WO2006025378A1/ja not_active Ceased
- 2005-08-30 KR KR1020077001596A patent/KR101244508B1/ko not_active Ceased
- 2005-08-30 DE DE602005024981T patent/DE602005024981D1/de not_active Expired - Lifetime
- 2005-08-30 CN CN2005800291311A patent/CN101010080B/zh not_active Expired - Lifetime
- 2005-08-30 AT AT05777087T patent/ATE489093T1/de active
- 2005-08-30 ES ES05777087T patent/ES2354366T3/es not_active Expired - Lifetime
- 2005-08-30 PL PL05777087T patent/PL1785137T3/pl unknown
- 2005-08-30 PT PT05777087T patent/PT1785137E/pt unknown
2006
- 2006-10-12 US US11/546,248 patent/US7459447B2/en not_active Expired - Lifetime
2011
- 2011-02-01 CY CY20111100106T patent/CY1111150T1/el unknown

Also Published As

Publication number	Publication date
DE602005024981D1 (de)	2011-01-05
US7459447B2 (en)	2008-12-02
PT1785137E (pt)	2010-12-23
JP4886516B2 (ja)	2012-02-29
CN101010080B (zh)	2011-02-09
ES2354366T3 (es)	2011-03-14
ATE489093T1 (de)	2010-12-15
EP1785137A1 (en)	2007-05-16
EP1785137A4 (en)	2007-12-19
CY1111150T1 (el)	2015-06-11
KR20070047766A (ko)	2007-05-07
JPWO2006025378A1 (ja)	2008-05-08
CN101010080A (zh)	2007-08-01
US20070032467A1 (en)	2007-02-08
US20060046996A1 (en)	2006-03-02
WO2006025378A1 (ja)	2006-03-09
EP1785137B1 (en)	2010-11-24
KR101244508B1 (ko)	2013-03-18
HK1110200A1 (en)	2008-07-11

Publication	Publication Date	Title
PL1785137T3 (pl)	2011-04-29	Środek do leczenia hiperlipemii
CY2019030I2 (el)	2020-05-29	Παραγωγο ραπαμυκινης για την θεραπευτικη αντιμετωπιση του καρκινου του πνευμονα
NO20050073L (no)	2005-01-06	Ringsubstituerte difenylazetidinoner, deres fremstilling, deres anvendelse samt legemidler inneholdende forbindelsene
WO2005046662A3 (en)	2005-06-23	Hdl-boosting combination therapy complexes
DE50311898D1 (de)	2009-10-22	Fredericamycin-derivate als arzneimittel zur tumorbehandlung
AU2003251563A1 (en)	2004-01-06	Implatable or insertable medical devices for controlled delivery of a therapeutic agent
WO2005002515A3 (en)	2005-07-14	Delivery of therapeutic compounds to the brain and other tissues
WO2005044192A3 (en)	2005-09-09	Triazole compounds and uses related thereto
WO2009005269A3 (en)	2009-02-26	Pharmaceutical composition for preventintion and treatment of restenosis comprising isoxazole derivatives
ATE257480T1 (de)	2004-01-15	Bicyclische pyrrolylamide als glycogenphosphorylase-inhibitoren
MY176938A (en)	2020-08-27	3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo[4,5-d] pyrimidin-2-one compounds and prodrugs thereof
AU2002366355A1 (en)	2003-06-30	SEQUESTRATION OF ABeta IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
PL2123271T3 (pl)	2012-03-30	Lek do leczenia grypy
ZA200703601B (en)	2008-09-25	Medicaments for the treatment or prevention of fibriotic diseases
ATE360633T1 (de)	2007-05-15	N-substituierte hydromorphone und ihre anwendung
EA201071006A1 (ru)	2011-02-28	Набор, композиция, продукт или лекарственное средство для лечения нарушения познавательной способности
TWI372056B (en)	2012-09-11	Novel medicament combinations for the treatment of respiratory diseases
AU2001263383A1 (en)	2001-12-03	Use of pyridinylimidazole carbamate derivate for the manufacture of a medicament for the treatment of cancer
AU2003210659A1 (en)	2003-09-02	Combination therapy for treatment of hiv infection
ATE326451T1 (de)	2006-06-15	Chinazolin derivate und therapeutische verwendungen davon
EP1753425A4 (en)	2009-08-05	THERAPEUTIC AGENT COMPRISING A NICOTINIC ACID OR DERIVATIVES AS AN EFFECTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF CANCER
ATE469642T1 (de)	2010-06-15	Vorbeugungs- oder heilmittel gegen endometriose
WO2003089449A3 (fr)	2004-04-01	Composes aminoalkylsteroles avec activite anti-tumeur et neuroprotective
TWI319321B (en)	2010-01-11	Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
ZA200609337B (en)	2008-08-27	Use of opioid antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin